This is a recorded version of the webinar on Diagnosis and Treatment of Acquired Hemophilia in Women During the Reproductive and Late Menopausal Life Stages that was presented live on November 20, 2014. Please scroll all the way down to view the archived webinar.
This Webinar was made possible in part by an education grant from Baxter Healthcare Corporation.
Webinar Launch Date: 04/01/15
Webinar Expiration Date: 07/01/16
Estimated Time to complete: 1 hour
Format: Archived Webinar
Target Audience: Primary Care Physicians, Specialty Physicians (Ob/Gyn, Oncology, Hematology), Physician Assistants, Advanced Nurse Practitioners, Registered Nurses, Licensed Practical Nurses, Registered Nurses in Specialty Areas (Ob/Gyn, Oncology, Hematology)
This purpose of this webinar is to provide evidence-based, practical information on the diagnosis and clinical management of women and girls with acquired hemophilia in postpartum women and women with advancing age. The presentation of this condition in women during these life stages, as well as the best diagnostic tools, optimal therapies, and treatment guidelines, are presented.
Activity Medical Director
Andra H. James, MD, MPH
Consulting Professor, Obstetrics & Gynecology,
Duke University Medical Center
Rebecca Kruse-Jarres, MD, MPH
Medical Director, Hemophilia Care Program, Puget Sound Blood Center
Associate Professor of Medicine and Pediatrics
University of Washington, Seattle, WA
Barbara A. Konkle, MD
Director, Clinical and Translational Research
Medical Director, Hemostasis Reference Laboratory, Puget Sound Blood Center
Professor of Medicine
University of Washington, Seattle, WA
Evelyn Lockhart, MD, Associate Medical Director of University of New Mexico Transfusion Service, and Associate Professor of Pathology at University of New Mexico School of Medicine, Albuquerque, NM
Learning Objectives and Goals
At the conclusion of this activity, learners should be able to:
- Recognize the signs and symptoms of acquired hemophilia within the clinical setting
- Discuss the diagnosis and optimal treatment of postpartum acquired hemophilia
- Discuss the diagnosis and optimal treatment of acquired hemophilia among older women in the later life stages
- Explain current guidelines for the optimal treatment of and management of postpartum women and women in later life stages with the diagnosis of acquired hemophilia to colleagues and residents
This session is jointly provided by The Duke University Health System Department of Clinical Education & Professional School of Medicine and the Foundation for Women & Girls with Blood Disorders.
This activity has been planned and implemented by the Duke University Health System Department of Clinical Education & Professional Development and Foundation for Women and Girls with Blood Disorders for the advancement of patient care. The Duke University Health System Department of Clinical Education & Professional Development is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for the healthcare team.
**Physicians: Duke University Health System Department of Clinical Education & Professional Development designates this 1.0 activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.
To Claim Continuing Education Credits
To complete all course requirements and claim Continuing Education Credits, please CLICK HERE.
Instructions to receive credit:
- Log-in or Register
- Review the materials on accreditation information, target audience, learning objectives, and disclosure information
- Complete the pre-test assessment
- View the archived webinar
- Complete the post-test self-assessment
- Attest to your hours of completion
- Submit an evaluation/claim form
- Download your certificate
Required: Windows® 8, 7, Vista, XP or 2003 Server
Required: Mac OS® X 10.6 or newer
Required: iPhone®, iPad®, Android™ phone or Android tablet